DrugPatentWatch Custom Market Surveillance
DrugPatentWatch’s Custom Market Surveillance provides you with a robust platform to monitor your business opportunities from every angle. You’re monitoring […]
DrugPatentWatch’s Custom Market Surveillance provides you with a robust platform to monitor your business opportunities from every angle. You’re monitoring […]
Before the passage of the Biologic Patent Transparency Act DrugPatentWatch’s biologic patent data was cited as a reason why the
This paper was originally published by Andreas H. Göller, Lara Kuhnke, Floriane Montanari, Anne Bonin, Sebastian Schneckener, Antoniuster Laak, Jörg
This paper was originally published by Md. Imtiaz Hasan et al in Journal of Biosciences and Medicines under a Creative Commons
This is my talk from the 14th Annual Portfolio Planning and Partnership for Generic Conference. I discuss: Identifying generic entry
Generic Portfolio Management, Partnering with Brands, and Staying Competitive Read Post »
I’ll be leading a workshop on generic portfolio management, and also giving a talk, at the 14th annual Marcus Evans
Upcoming workshop on generic portfolio management Read Post »
Come join me and Wendi Lau from Abbvie as we participate in an interactive roundtable discussion on pharmaceutical portfolio management.
DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management Read Post »
When it comes to pricing generic drugs, there are a number of factors that come into play. In countries without
Want insights into the biggest revenue-changing events? ➤ Get Your Certificate Today By tracking patent expirations, patent litigation, generic and
Free Course in Generic and Branded Drug Lifecycle Management Read Post »